Generics

Filter

Current filters:

None

Popular Filters

60 to 84 of 1140 results

AMRI to develop parenteral drug products with Genovi

13-01-2015

Albany Molecular Research has entered into several development and supply agreements with the UK’s…

Albany Molecular ResearchEuropeGenericsGenovi PharmaceuticalsMarkets & MarketingProductionUSA

Helsinn settles with Sandoz over Aloxi in USA

12-01-2015

Privately-held Swiss cancer specialist Helsinn Group say it has entered into a settlement agreement with…

AloxiEisaiGenericsHelsinn GroupLegalNovartisOncologyPatentsSandozUSA

Health Canada instigates quarantine of products from Sri Krishna Pharmaceuticals

Health Canada instigates quarantine of products from Sri Krishna Pharmaceuticals

07-01-2015

At Health Canada's request, Canadian importers have agreed to quarantine health products made with active…

CanadaGenericsIndiaItalyRegulationSri Krishna Pharmaceuticals

Russian government takes steps to prevent further drug price increases

Russian government takes steps to prevent further drug price increases

05-01-2015

The Russian government is designing a number of measures aimed at preventing a further increase of drug…

GenericsPricingRussia

Leading Russian drugmakers suspend production of cheap drugs

Leading Russian drugmakers suspend production of cheap drugs

24-12-2014

Some 16 leading Russian pharmaceutical companies have officially announced suspension of the production…

GenericsKalashnikovPricingProductionRussia

FTC reports 2013 patent dispute settlements, with 29 potential pay-for-delay deals

FTC reports 2013 patent dispute settlements, with 29 potential pay-for-delay deals

23-12-2014

In fiscal year 2013, companies filed a total of 145 final patent dispute settlements, of which 29 created…

GenericsLegalUSA

New Indian moves on pharma pricing

New Indian moves on pharma pricing

22-12-2014

Early January 2015, the Indian government is to come out with a new list of life saving drugs whose prices…

GenericsPoliticsPricing

UCB, Advent and Avista Capital terminate $1.5 billion divestment agreement

UCB, Advent and Avista Capital terminate $1.5 billion divestment agreement

17-12-2014

Belgian drugmaker UCB and private equity firms Avista Capital and Advent International have mutually…

BelgiumBusiness FinanceConcertaGenericsUCB

With buy of Veropharm, Abbott to significantly increase revenue in Russia

With buy of Veropharm, Abbott to significantly increase revenue in Russia

17-12-2014

US drugmaker Abbott plans to significantly increase its revenue in the Russian market over the next several…

AbbottFinancialGenericsMarkets & MarketingProductionRussiaVeropharm

Ranbaxy may establish production in Russia

Ranbaxy may establish production in Russia

16-12-2014

Generic pharma company Ranbaxy, one of India’s largest drugmakers which is in the process of being…

Antibiotics and Infectious diseasesGenericsNeurologicalProductionRanbaxyRussia

Actavis files emergency appeal against District Court decision on Namenda

Actavis files emergency appeal against District Court decision on Namenda

16-12-2014

Ireland-headquartered generics major Actavis is filing an emergency appeal to the US Court of Appeals…

ActavisGenericsLegalNamendaNeurologicalUSA

Daiichi Sankyo launches new generic drugs

Daiichi Sankyo launches new generic drugs

15-12-2014

Japanese pharma major Daiichi Sankyo says its generics subsidiary, Daiichi Sankyo Espha, has launched…

Antibiotics and Infectious diseasesBlopressCardio-vascularCravitDaiichi SankyoElplatGenericsJapanMarkets & MarketingOncology

India revisits plans for free generic medicines, drug price fixing

India revisits plans for free generic medicines, drug price fixing

11-12-2014

Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing…

FinancialGenericsHealthcareIndiaPharmaceuticalPoliticsPricing

Teva issues 2015 business outlook short of expectations

Teva issues 2015 business outlook short of expectations

11-12-2014

Israel-based generics giant Teva Pharmaceutical Industries saw its shares gain 1.17% to $57.05, despite…

CopaxoneFinancialGenericsIsraelPulmicortTeva Pharmaceutcal Industries

US generic trade group supports compromise legislation for biosimilars

US generic trade group supports compromise legislation for biosimilars

11-12-2014

The USA's Generic Pharmaceutical Association (GPhA) has agreed to support compromise automatic substitution…

BiosimilarsGenericsLegalRegulationUSA

Supernus notified of Par Pharma ANDA filing for Trokendi XR generic

09-12-2014

US drugmaker Supernus Pharmaceuticals says that it has received a Paragraph IV Notice Letter from privately-held…

GenericsNeurologicalPar PharmaceuticalsPatentsRegulationSupernus PharmaceuticalsTrokendi XRUSA

Europe’s research and generic/biosimilar industries join forces against counterfeiting

Europe’s research and generic/biosimilar industries join forces against counterfeiting

09-12-2014

Trade groups the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European…

ESMEuropeGenericsMarkets & MarketingPharmaceutical

AstraZeneca wins in US Nexium pay-for-delay litigation

AstraZeneca wins in US Nexium pay-for-delay litigation

07-12-2014

Anglo-Swedish pharma major AstraZeneca revealed on Friday that a jury in the US District Court for the…

AstraZenecaGastro-intestinalsGenericsLegalNexiumPatentsRanbaxyUSA

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

05-12-2014

The US Food and Drug Administration has granted tentative approval for New Drug Applications by US generic…

Abacavir Sulfate and Lamivudine TabletsAnti-viralsGenericsMylanRegulationUSA

60 to 84 of 1140 results

Back to top